CRO Health Decisions Announces Women’s Health Initiative
Clinical Research Organization Marks World Contraception Day with Strategic Commitment to Clinical Development in Women’s Health
Durham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, today announced an initiative that strengthens and expands its capabilities in development of women’s health products.
“World Contraception Day is a fitting occasion for Health Decisions to announce an initiative that strengthens and expands our commitment to clinical development of products to improve healthcare outcomes for women,” said Patrick Phillips, D. Phil., Health Decisions’ Chief Executive Officer. “We have played an important role in development of a variety of products that increase the range of safe and acceptable contraceptives available to women. We also serve as Statistical and Clinical Coordinating Center for the Contraceptive Clinical Trials Network of the National Institutes of Health. Today we are announcing that in addition to naming Andrea Lukes, a distinguished board-certified OB/GYN with extensive experience in clinical development, as our Chief Medical Officer, Health Decisions will expand our Scientific Advisory Board and add clinical development staff to bolster our already strong capabilities in key therapeutic areas including gynecologic oncology and breast cancer.” Health Decisions announced the appointment of Dr. Lukes as CMO on September 20.
“I joined Health Decisions because it is already a leader in clinical development of women’s health products and has a commitment to establishing global leadership in the field,” said Dr. Lukes, a Fellow of The American Congress of Obstetricians and Gynecologists and founder of the Carolina Women’s Research and Wellness Center (CWRWC), a research center focused on women’s health. Dr. Lukes also established the Women’s Wellness Clinic, a leading private gynecologic practice and clinical research center within CWRWC. “At Health Decisions, we have an opportunity to provide market-leading services to sponsors of products addressing the significant unmet medical needs of girls and women of all ages. We understand the needs of developers of women’s health products and are further strengthening a therapeutic and operational team for women’s health studies that is already second to none. We invite sponsors and principal investigators to visit the new Health Decisions website for an indication of the depth and breadth of Health Decisions’ organizational commitment to women’s health.”
“This initiative reflects our vision and strategic intent,” Dr. Phillips said. “We are excited that this will be reflected in our scientific, medical and operational leadership and expertise in women’s health studies.”
About Health Decisions
Health Decisions is a full-service CRO offering therapeutic, operational and regulatory excellence for clinical development of drugs, diagnostics, medical devices and combination drug/devices in all areas of women’s health. Based on therapeutic and operational experience and investigator relationships developed in studies conducted over the past 28 years, Health Decisions successfully addresses the challenges of developing products in areas including reproductive and sexual health, menopause, pain management, osteoporosis/osteoarthritis, reproductive psychiatry, gynecologic oncology and general gynecology indications. If it matters to women’s health, it matters to Health Decisions. Health Decisions is headquartered in Durham, NC.
# # #
Senior Marketing Specialist
+1 919.967.1111 ext. 520
lhammill @ healthdec.com